Boston Scientific posted Q4 revenue of $4.56 billion, surpassing estimates. The company forecasts 2025 sales growth of up to 14.5% and EPS of $2.80-$2.87.

Boston Scientific (NYSE: BSX) shares ticked up slightly before hours today on fourth-quarter results that beat the consensus ...

Boston Scientific (NYSE:BSX) reported fiscal Q4 2024 results that surpassed analyst expectations. The company's shares swung between gains and losses in premarket trading Wednesday. The company ...

Explore the debate on climate change causes: human activities vs. natural variability. Discover the latest data, scientific ...

Several Kentucky bills filed this legislative session have one thing in common: a shared skepticism of guidance from top U.S.

Trump's pick to run the Department of Health and Human Services gave away the agenda -- and may have invited a strong legal ...

Boston Scientific (BSX) came out with quarterly earnings of $0.70 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.55 per share a year ago. These ...

The man who hopes to be President Donald Trump’s health secretary says he needs to see data showing vaccines are safe, but he ...

For fiscal year 2027, Eurofins reiterated an average of 6.5% organic growth and confirmed a 24% EBITDA margin target, although it has abandoned its €10 billion revenue goal and now expects further ...

The S&P 500 Index ( $SPX) ( SPY) today is up +0.24%, the Dow Jones Industrials Index ( $DOWI ) ( DIA) is up +0.33%, and the Nasdaq 100 Index ( $IUXX) ( QQQ) is up +0.17%. March E-mini S&P futures ( ...